Embolization of liver tumors: Past, present and future
Authors:
- Ashwin RammohanARAshwin Rammohan
- Jeswanth SathyanesanJSJeswanth Sathyanesan
- Sukumar RamaswamiSRSukumar Ramaswami
- Anand LakshmananALAnand Lakshmanan
- Perumal Senthil-KumarPSPerumal Senthil-Kumar
- Ulagendra Perumal SrinivasanUSUlagendra Perumal Srinivasan
- Ravi RamasamyRRRavi Ramasamy
- Palaniappan RavichandranPRPalaniappan Ravichandran
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Radiology
- Vol. 4 (9) , 405-12
Abstract
Curative therapies for hepatocellular carcinoma (HCC), such as resection and liver transplantation, can only be applied in selected patients with early tumors. More advanced stages require local or systemic therapies. Resection of HCC offers the only hope for cure. Even in patients undergoing resection, recurrences are common. Chemoembolization, a technique combining intra-arterial chemotherapy with selective tumor ischemia, has been shown by randomized controlled trials to be efficacious in the palliative setting. There is now renewed interest in transarterial embolization/transarterial chemoembolization (TACE) with regards to its use as a palliative tool in a combined modality approach, as a neoadjuvant therapy, in bridging therapy before transplantation, for symptomatic indications, and even as an alternative to resection. There have also been rapid advances in the agents being embolized trans-arterially (genes, biological response modifiers, etc.). The current review provides an evidence-based overview of the past, present and future trends of TACE in patients with HCC.Keywords
This publication has 84 references indexed in Scilit:
- Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis2012
- Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine TumorsInternational Journal of Hepatology, 2012
- Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review.Hepatogastroenterology, 2012
- Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysisJournal of Cancer Research and Clinical Oncology, 2011
- Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluationHepatology, 2011
- Evaluation of tumor response after locoregional therapies in hepatocellular carcinomaCancer, 2009
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled TrialsRadiology, 2002
- Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal veinWorld Journal of Gastroenterology, 2001
- Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.Radiology, 1996
- Symptom relief and survival after chemo‐embolization with Adriamycin, Lipiodol and Gelfoam for hepatocellular carcinomaAustralasian Radiology, 1993